申请人:LILLY CO ELI
公开号:WO2001094306A2
公开(公告)日:2001-12-13
The present invention provides bissulphonamide derivatives of formula (I), in which R1 represents C¿1-6?-alkyl, C2-6-alkenyl, or NR?7R8,R2 and R3¿ each independently represent hydrogen, C¿1-4?.alkyl, F, aryl, or C1-6.alkylaryl; R?4 and R5¿ each represent hydrogen; R6 represents C¿1-6?-alkyl; n is an integer from 7 to 14; and R?7 and R8¿ each independently represent hydrogen or C¿1-4?-alkyl; or a pharmaceutically acceptable salt thereof. Bissulphonamide derivatives of formula (I), in which R?1¿ represents C¿1-6?-alkyl, C2-6-alkenyl, or NR?7R8, R2, R2, R4, and R5¿ each represent hydrogen; R6 represents C¿1-6?-alkyl; n is an integer from 6 to 14; and R?7 and R8¿ each independently represent hydrogen or C¿1-4?-alkyl; or a pharmaceutically acceptable salt thereof; are useful for potentiating glutamate receptor function in a mammal and, therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.